Every year around 20 children in Sweden are diagnosed with Neuroblastoma, most before even turning 5 years of age. It is a rare and complexed tumor almost exclusively found among children. Research progress has been good and today around 80% survive, although resistance to medication is still a big problem for many individuals and today’s treatment will often lead to lifelong issues for the patient.

• By conducting a thorough screening of different medicines, looking for synergies to find the best combination that can complement or replace today’s treatment. Our hope is to contribute with heightened insight and new medical candidates in childhood cancer, says Daniel Bexell.

Originale article in Swedish via this link.